ALOX12 (Gene)

Organism:

Homo sapiens

Synonyms:12-LOX, 12S-LOX, ALOX12, ENTREZ:239, HGNC:429, LOG12, MIM:152391, NM_000697, NP_000688, XM_011523780, XP_011522082, arachidonate 12-lipoxygenase, 12S type

Omim:OMIM:152391

Id:e2b8f083-9c15-5337-bc0a-078055c309c5

Hgnc:HGNC:429

Entrez:239

Ensembl:ENSG00000108839

Description:arachidonate 12-lipoxygenase, 12S type

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View ALOX12's neighborhood in the knowledge graph.

Submit

Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with ALOX12.

CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using ALOX12.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for ALOX12.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with ALOX12.

Results found

Linked to

	Label	Description
	GSE202434 GSE202438 talazoparib 4 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE129698 SYK inhibition 3 v 4 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE77108 saha 0 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE185519 4 V 5 GILTERITINIB HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE202434 GSE202438 talazoparib 4 v 14 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE202434,GSE202438 4 V 0 TALAZOPARIB HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE188570 GSE188571 decitabine 5 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE129698 SYK inhibition 7 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE77108 0 V 2 SAHA HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE196035 GSE196037 MEN1 inhibition 8 v 11 human dn Gene Set (Entity type)	A Gene Set from LINCS

GSE202434 GSE202438 talazoparib 4 v 0 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE129698 SYK inhibition 3 v 4 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE77108 saha 0 v 2 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE185519 4 V 5 GILTERITINIB HUMAN DN

Gene Set (Entity type)

A Gene Set from LINCS

GSE202434 GSE202438 talazoparib 4 v 14 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE202434,GSE202438 4 V 0 TALAZOPARIB HUMAN DN

Gene Set (Entity type)

A Gene Set from LINCS

GSE188570 GSE188571 decitabine 5 v 2 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE129698 SYK inhibition 7 v 0 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE77108 0 V 2 SAHA HUMAN DN

Gene Set (Entity type)

A Gene Set from LINCS

GSE196035 GSE196037 MEN1 inhibition 8 v 11 human dn

Gene Set (Entity type)

A Gene Set from LINCS

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

CFDE Workbench

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.